Cargando…
Diverse Mechanisms Regulate the Surface Expression of Immunotherapeutic Target CTLA-4
T-cell co-receptor cytotoxic T-cell antigen-4 (CTLA-4) is a critical inhibitory regulator of T-cell immunity and antibody blockade of the co-receptor has been shown to be effective in tumor immunotherapy. Paradoxically, the majority of CTLA-4 is located in intracellular compartments from where it is...
Autores principales: | Schneider, Helga, Rudd, Christopher E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255484/ https://www.ncbi.nlm.nih.gov/pubmed/25538704 http://dx.doi.org/10.3389/fimmu.2014.00619 |
Ejemplares similares
-
CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy
por: Brunner-Weinzierl, Monika C., et al.
Publicado: (2018) -
Rab8 Binding to Immune Cell-Specific Adaptor LAX Facilitates Formation of trans-Golgi Network-Proximal CTLA-4 Vesicles for Surface Expression
por: Banton, Matthew C., et al.
Publicado: (2014) -
Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs
por: von Gunten, Stephan, et al.
Publicado: (2023) -
Current understanding of CTLA-4: from mechanism to autoimmune diseases
por: Hossen, Md Munnaf, et al.
Publicado: (2023) -
Cytotoxic T Lymphocyte Antigen 4 and CD28 Modulate Cell Surface Raft Expression in Their Regulation of T Cell Function
por: Martin, Margarita, et al.
Publicado: (2001)